Market Share of Europe Diabetes Drugs Industry
The European Diabetes Drugs Market is fragmented with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones. These measures taken by the market players will ensure a competitive marketplace, forcing companies to experiment with new technologies.
Europe Diabetes Drugs Market Leaders
Eli Lilly
Astrazeneca
Novo Nordisk
Sanofi
Boehringer Ingelheim
*Disclaimer: Major Players sorted in no particular order
